Rapport Therapeutics (RAPP) Depreciation and Depletion (2023 - 2026)
Rapport Therapeutics (RAPP) has 4 years of Depreciation and Depletion data on record, last reported at $200000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion changed 0.0% to $200000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.0 million, a 25.0% increase, with the full-year FY2025 number at $1.0 million, up 25.0% from a year prior.
- Depreciation and Depletion reached $200000.0 in Q1 2026 per RAPP's latest filing, roughly flat from $200000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for RAPP hit a ceiling of $300000.0 in Q2 2025 and a floor of $23000.0 in Q3 2023.
- A 4-year average of $180333.3 and a median of $200000.0 in 2024 define the central range for Depreciation and Depletion.
- Peak YoY movement for Depreciation and Depletion: surged 769.57% in 2024, then changed 0.0% in 2025.
- Tracing RAPP's Depreciation and Depletion over 4 years: stood at $41000.0 in 2023, then skyrocketed by 387.8% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- Business Quant data shows Depreciation and Depletion for RAPP at $200000.0 in Q1 2026, $200000.0 in Q4 2025, and $300000.0 in Q3 2025.